Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: The discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics
Crossref DOI link: https://doi.org/10.1038/s41429-019-0241-5
Published Online: 2019-10-04
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kimura, Ken-ichi
Text and Data Mining valid from 2019-10-04
Version of Record valid from 2019-10-04
Article History
Received: 19 July 2019
Revised: 17 September 2019
Accepted: 17 September 2019
First Online: 4 October 2019
Compliance with ethical standards
:
: The author declares that he has no conflict of interest.